1. Effect of omalizumab on angioedema in H1‐antihistamine‐resistant chronic spontaneous urticaria patients: results from X‐ACT, a randomized controlled trial. Issue 8 (31st March 2016) Authors: Staubach, P.; Metz, M.; Chapman‐Rothe, N.; Sieder, C.; Bräutigam, M.; Canvin, J.; Maurer, M. Journal: Allergy Issue: Volume 71:Issue 8(2016:Aug.) Page Start: 1135 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Response to: 'Omalizumab for the treatment of chronic idiopathic or spontaneous urticaria: a critical appraisal'. (1st July 2014) Authors: Rosén, K.; Maurer, M.; Hsieh, H.; Saini, S.; Grattan, C.; Gimenéz‐Arnau, A.; Agarwal, S.; Doyle, R.; Canvin, J.; Kaplan, A.; Casale, T. Journal: British journal of dermatology Issue: Volume 171:Number 1(2014:Jul.) Page Start: 15 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Response to: 'Omalizumab for the treatment of chronic idiopathic or spontaneous urticaria: a critical appraisal'. (July 2014) Authors: Rosén, K.; Maurer, M.; Hsieh, H.; Saini, S.; Grattan, C.; Gimenéz‐Arnau, A.; Agarwal, S.; Doyle, R.; Canvin, J.; Kaplan, A.; Casale, T. Journal: British journal of dermatology Issue: Volume 171:Number 1(2014:Jul.) Page Start: 15 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗